CBMG
Cellular Biomedicine Group, Inc.
CBMG
CBMG
Delisted
CBMG was delisted on the 19th of February, 2021.
41 hedge funds and large institutions have $67.3M invested in Cellular Biomedicine Group, Inc. in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
35% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 17
Holders
41
Holding in Top 10
–
Calls
$232K
Puts
$260K
Top Buyers
| 1 | +$2.22M | |
| 2 | +$540K | |
| 3 | +$123K | |
| 4 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
+$98.1K |
| 5 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
+$69.4K |
Top Sellers
| 1 | -$2.59M | |
| 2 | -$888K | |
| 3 | -$888K | |
| 4 |
Two Sigma Investments
New York
|
-$341K |
| 5 |
Morgan Stanley
New York
|
-$249K |